SARS-CoV-2 and Microbiota

Journal of Probiotics & Health(2020)

引用 0|浏览1
暂无评分
摘要
This letter exposes some of the many reasons why microbiotamodulation in patients with COVID-19 disease and more ingeneral, in all people at greatest risk of contracting SARS-CoV2virus infections, should be taken into consideration.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要